Wikipedia -WSS

Wikipedia

author：fashion 2025-09-07 04:07:13 - browse：22433

Christine Kao/STAT

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies.

PBMs, the middlemen of drug pricing negotiations, also claim portions of those lucrative rebates for themselves. So when new market developments threaten to diminish or wipe away that revenue stream, PBMs find crafty ways to keep as much of those dollars as possible — often at the expense of employers.

One such case occurred last year, when a wave of Humira biosimilars entered the market and drug companies slashed the list prices of their insulin products. CVS Caremark, the PBM owned by CVS Health that oversees the prescription drug benefits of 103 million people, told its employer clients that it anticipated “more lower-cost products (including specialty biosimilars) may become preferred products” on its lists of approved drugs for 2024, according to documents obtained by STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Physician executives need more than on

WSS

Eli Lilly to pay $200M for Beam’s stake in gene

Bill would stop addiction treatment from triggering child abuse inquiry

Analysis of telehealth claims data suggest service duplication

FDA authorizes Novavax’s updated Covid

Readout Newsletter: What happened with Sarepta's Duchenne data

Readout Newsletter: What happened with Sarepta's Duchenne data

leisure time

Wikipedia

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

Analysis of telehealth claims data suggest service duplication

Wildfire smoke exposes gaps in outdoor worker protections

Bristol 'take

DIEP, the 'gold standard' of breast reconstruction, is under threat

Physician subsidies by hospitals soar in wake of No Surprises Act

In age of alternative facts, a scholarly course on calling out crap

Bristol 'take

Peter Hotez and the public health issue of online harassment

Analysis of telehealth claims data suggest service duplication

leisure time

The pink breast cancer awareness ribbon needs a redesign

Bristol 'take

Why age limits for politicians are a terrible idea

Bill would stop addiction treatment from triggering child abuse inquiry

Senate panel to vote on hospitals, PBMs, prisoner care

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

explore

explore

hotspot

hotspot